Should PPIs be given to patients on antiplatelet drugs?
Original article Ibáñez L et al. (2006) Upper gastrointestinal bleeding associated with antiplatelet drugs. Aliment Pharmacol Ther 23: 235–242 PubMedAntiplatelet drug use is associated with an increased risk of upper gastrointestinal bleeding (UGIB); data on the impact of gastroprotective agents, such as PPIs, in this setting are, however, lacking.